BP1263

Trans-4-(Aminomethyl)cyclohexancarboxylsäure

British Pharmacopoeia (BP) Reference Standard

• Synonym(e): HAKU, TAMCHA, Tranexamsäure
• Lineare Formel: H₂NCH₂C₆H₁₀CO₂H
• CAS-Nummer: 1197-18-8
• Molekulargewicht: 157.21
• Beilstein: 2207452
• MDL-Nummer: MFCD00001466
• UNSPSC-Code: 12352106
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: tranexamic acid
• Form: crystalline
• Haltbarkeit: limited shelf life, expiry date on the label
• Hersteller/Markenname: BP
• mp (Schmelzpunkt): >300 °C (lit.)
• Anwendung(en): pharmaceutical; pharmaceutical small molecule
• Format: neat
• Lagertemp.: 2-8°C
• SMILES String: NC[C@H]1CC[C@@H](CC1)C(O)=O
• InChI: 1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7-
• InChIKey: GYDJEQRTZSCIOI-LJGSYFOKSA-N

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Tranexamic acid BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Tranexamic Acid Injection

Tranexamic Acid Oral Solution

Verpackung

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H315,H319,H335
• P-Sätze: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Gefahreneinstufungen: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Zielorgane: Respiratory system
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 2
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable